NCT01130753
- Conditions
- Erlotinib, Lung Diseases, Lung Neoplasms, +6 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Erlotinib. Study availability and eligibility vary by location and protocol.
NCT01130753